Polyglycol modifying ferric iron deuterohemin short peptide compound and production method thereof
A technology of polyethylene glycol succinimidyl ester and polyethylene glycol, applied in the biological field, can solve problems such as low bioavailability, and achieve the effects of simple modification method, good stability and high yield
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0033] Methoxy polyethylene glycol succinimide carbonate (see the general formula for the structure, k=0, the weight-average molecular weight of PEG is 20000, n≈447) (m-SC-PEG20000) to subheme hexapeptide (DhHP -6) modification:
[0034] The choice of reaction temperature: DhHP-6 solid powder is dissolved in deionized water, is mixed with the DhHP-6 deionized aqueous solution of 1mg / ml, gets 4 parts of 0.1ml DhHP-6 deionized aqueous solution (1mg / ml), with pH =7 phosphate buffered saline (PBS) was diluted to 1ml, and 20mg m-SC-PEG20000 was added respectively (the following refers to the molar ratio, and the molar ratio is approximately equal to (20 / 20000) / (0.1 / 1000)=10:1) , after completely dissolving, placed in the environment of 0°C, 4°C, 15°C, and 25°C for 1 hour, and then added glycine to terminate the reaction. Detect conversion rate with reverse phase high-performance liquid chromatography, record its conversion rate to be 37.1%, 38.5%, 47.9% and 55.1% respectively, the...
Embodiment 2
[0039] Example 2: Separation, purification and identification of modified products
[0040] Dissolve DhHP-6 solid powder in deionized water to prepare 1mg / ml DhHP-6 deionized aqueous solution, take 0.1ml DhHP-6 deionized aqueous solution (1mg / ml), and use pH=8 phosphate buffer (PBS) was diluted to 1ml, and 20mg of m-SC-PEG20000 was added. After it was completely dissolved, it was placed in an environment at 25°C. After reacting for 2 hours, glycine was added to terminate the reaction.
[0041] The upper column separation of the above reaction solution, the chromatographic conditions are as follows:
[0042] Chromatograph: BioCAD 700E;
[0043] Column specifications: prepLC, 25mmModule;
[0044] Flow rate: 10ml / min;
[0045] Mobile phase: A:H 2 O (containing 0.5% trifluoroacetic acid (TFA, v / v)), B: 90% aqueous acetonitrile (containing 0.5% trifluoroacetic acid (TFA, v / v));
[0046] Concentration gradient: elution time 0-5min, 100% A phase, elution time 5-45min, B phase gr...
Embodiment 3
[0050] Embodiment 3: the biological activity (specific activity) measurement of modification product
[0051] The microenzyme that hydrolyzes with cytochrome c, MP-9 is used as standard substance contrast, with ascorbic acid (V C ) and H 2 o 2 As the substrate, the peroxidase activity of DhHP-6 and PEG-DhHP-6 was determined, and the specific activity of DhHP-6 was 4.0×10 3 U / μmol, while the specific activity of PEG-DhHP-6 is 3.1×10 3 U / μmol (defining the amount of enzyme needed to oxidize 1 μg VC per minute as an activity unit U), the results are shown in Table 1: as can be seen from the table, PEG-modified DhHP-6 still has a high activity, indicating that this modification method is feasible.
[0052] Table 1: Specific activities of DhHP-6 and PEG-DhHP-6
[0053] sample
PUM
Property | Measurement | Unit |
---|---|---|
wavelength | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com